Safety and Tolerability of hRPC in Retinitis Pigmentosa
NCT02464436
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
29
Enrollment
INDUSTRY
Sponsor class
Conditions
Retinitis Pigmentosa
Interventions
DRUG:
hRPC
Sponsor
ReNeuron Limited